RESEARCH 2006
RESEARCH 2005
RESEARCH 2004
RESEARCH 2003
> Dr. James Anderson
> Dr. James Buchanan
> Dr. James Courtright
> Dr. Jane E. Dorweiler
> Dr. Stephen Downs
> Dr. Robert Fitts
> Dr. James Maki
   - Alissa R. DeHaan
   - Jenny Strickland
> Dr. Michael Schläppi 
> Dr. Rosemary A. Stuart
> Dr. Gail Waring
> Dr. Pinfen Yang
   - Zagum Bhatti
   - Jennifer Dienes
   - Susan R. Hupp

RESEARCH 2002
RESEARCH 2001
RESEARCH 2000

 

 

Baclofen induced activation of GABAB receptors facilitate calcium current in low concentrations and inhibit calcium currents in high concentrations

Kathryn A. Gniotczynski
Marquette University
Milwaukee, WI
Mentor: Dr. Michelle Mynlieff

GABA is the main inhibitory neurotransmitter in the vertebrate central nervous system, and are receptors involved in modulation. It has been previously shown that activation of GABAB receptors has an inhibitory effect on synaptic activity, and there is growing evidence that GABAB receptors are also involved in a facilitory effect by up-regulating high-voltage activated calcium channels. Since previous studies have shown two opposing effects of GABAB receptor activation, there is the possibility that there could be two GABAB receptor subtypes. Prior experiments in our lab showing facilitation and inhibition were carried out using the GABAB agonist baclofen at a single concentration of 10mM. Shen & Slaughter (1999) demonstrated that salamander retinal cells also responded with both an inhibition and a facilitation of calcium currents with the activation of GABAB receptors using baclofen. However in their experiments a single cell had both effects which produced a dose response curve showing inhibition of calcium currents at high concentrations of baclofen (300mM) and at low concentrations (500nM) facilitation. The objective of the present study was to determine whether a dual dose response curve is also seen in hippocampal cells in the response to baclofen. Prior to attempting a full dose response curve, it was necessary to address the problem of rundown. Creatine an ATP regenerator was added to the internal solution in an attempt to decrease rundown of calcium currents. 

Whole-cell voltage clamp recording was used in all experiments. The cultured hippocampal neurons of 5 to 7 day old pups were kept at a holding potential of –80mV. Depending on the experiment the cells were given depolarizing pulses in the range of –50mV to +50mV to elicit calcium currents. Six cells were tested for rundown, three were recorded from using the original solution, and the other three were recorded from using the mixture of the original and the new internal solution with creatine. Two components, peak and sustained, of the calcium currents were analyzed and a rundown rate was calculated. The original solution had a peak rundown rate of –11.1%/min ± 7.41 and a sustained of -6.54 ± 3.56. The currents of the cells using the mixture of internal solutions had a peak of -7.53 ± 7.12 and a sustained of -1.93 ± 5.28. There was no significant difference in the rundown of either the peak or the sustained components between the two internal solutions. The baclofen cell showed peak inhibition of 12.4% at 1mM and peak facilitation of 18.6% at 500nM. The sustained component only showed facilitation of 40.5% at a baclofen concentration of 500nM. 

Although the rundown data showed no significant difference between solutions the standard deviation was too large to conclude anything. The baclofen data is promising and follows the suspected hypothesis that there is a dual dose response curve in hippocampal neurons. 


 

<Summer Research Program Home
 

All material 2003 © Marquette University.